Mounjaro®
Starting from £179.99/mo
Start journey Learn moreComing off semaglutide gradually, with a plan in place for diet and activity, gives you the best chance of holding on to the weight you've lost. There is no single protocol that suits everyone, and stopping suddenly carries a real risk of rapid regain — so the way you come off matters as much as the decision to stop. Semaglutide (Wegovy) is a prescription-only medicine; how and when to stop should always be discussed with your prescriber, who can weigh your current dose, your health picture and your goals before making a plan.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors that slow gastric emptying and reduce appetite signals in the brain. While you're taking it, eating less feels natural. When the medicine clears your system (semaglutide has a half-life of roughly a week, so it takes several weeks to fully wash out) those appetite signals return, often forcefully. Hunger can feel louder than it did before you started, partly because the body treats recent weight loss as a deficit it wants to correct.
Clinical data bear this out. Participants in the STEP 1 trial who stopped semaglutide at 68 weeks regained around two-thirds of their lost weight over the following year, as documented in the original STEP 1 paper published in the New England Journal of Medicine. That figure isn't a reason to despair; it is a reason to plan. People who had built robust lifestyle habits alongside treatment recovered more ground than those who hadn't. You can read more about protecting your weight loss after stopping Wegovy in our dedicated guide.
The emotional side of this is real too. Many people feel anxious about stopping, particularly after months of effort. That anxiety makes sense, and it's worth naming it, then channelling it into preparation rather than avoidance.
There is no formal NHS tapering protocol for semaglutide in the way that exists for, say, steroids. The SmPC does not specify a mandatory step-down schedule before stopping. That said, most prescribers prefer a gradual reduction (stepping down through lower doses over several weeks) rather than going from 2.4mg (or 7.2mg) to nothing in one go. The rationale is practical: a slower exit gives your appetite and digestion time to re-adjust, and it gives you and your prescriber a clearer picture of how your body responds at each stage.
What this looks like in practice depends on the dose you're currently taking and how long you've been on treatment. Someone who has been at 2.4mg for eighteen months will likely need a different plan to someone who reached 1.7mg and wants to pause. The question of whether stopping is even the right call at this point is itself worth revisiting, our overview of who typically comes off semaglutide and why covers this in more detail. Your prescriber is the right person to draw up the specifics.
Self-tapering without clinical input is not advisable. If you're treating type 2 diabetes alongside weight management, changing your semaglutide dose independently can affect blood glucose in ways that need monitoring. Even for weight management alone, an unstructured step-down can make it harder to attribute any symptoms to the right cause. A short conversation with your prescriber is time well spent. If you want a clear picture of what a structured step-down actually involves, our guide on how to come off Wegovy walks through the process in practical detail.
This is where the real work sits, and being honest about it upfront makes the transition less of a shock. The NHS patient information on semaglutide is consistent with clinical guidance in emphasising that the medicine is designed to work alongside a reduced-calorie diet and increased physical activity, not instead of them. When the drug's appetite-suppressing effect fades, those habits need to be robust enough to carry you.
Practically, this means three things tend to matter most. First, protein intake: adequate protein (roughly 1.2–1.6g per kilogram of body weight per day, though your prescriber or a dietitian can personalise this) supports satiety and preserves lean muscle mass during weight loss. Second, resistance exercise: muscle tissue is metabolically active and helps maintain a higher resting calorie burn; people who added strength training during treatment tend to see smaller regain. Third, eating patterns rather than calorie counting: regular meals, fibre-rich foods, and awareness of hunger cues give you tools that work even when the medicine isn't there to blunt appetite. Our page on supporting weight loss on Wegovy covers the lifestyle evidence in more depth.
One practical note: if you're considering coming off Wegovy to manage cost, it is worth looking at what an all-inclusive private prescription actually involves, how Wegovy is dispensed through a regulated UK pharmacy differs considerably from what some cheaper listings offer, and the comparison changes the sums.
Several situations make stopping semaglutide the obvious next step: you've reached a weight your clinician considers healthy and stable, you're planning a pregnancy (the medicine is not recommended in pregnancy, breastfeeding or when actively trying to conceive), or you're experiencing side effects that outweigh the benefits. NICE's appraisal of semaglutide, TA875, includes a clinical benchmark: if fewer than 5% of body weight has been lost after six months at the maintenance dose, continuing treatment should be reviewed. That's a useful signal, though the decision is always individual.
Other situations are less clear-cut. If you've lost weight but feel uncertain about maintaining it, the answer might be a structured pause with a plan to restart, rather than a permanent stop. If cost is the main driver, a conversation with a prescriber may surface options you haven't considered. For a broader picture of how long people typically stay on treatment and what the evidence says about duration, our guide to how long semaglutide treatment typically lasts is a good place to start. And if you're already thinking about what comes next, exploring all available licensed treatment options may help frame the decision.
If you'd like a prescriber to review your current situation and help you build a stopping plan, a free consultation with our clinical team is the natural first step. Start your free consultation and one of our GPhC-registered prescribers will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.